Capital expenditure · 2016–2025
Arcus Biosciences capital expenditure
$2.0M−66.7% · FY2025
Arcus Biosciences (RCUS) reported $2.0M in capital expenditure for fiscal 2025, −66.7% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $2.0M | −66.7% | Open → |
| FY20242024-12-31 | $6.0M | −75.0% | Open → |
| FY20232023-12-31 | $24.0M | +300.0% | Open → |
| FY20222022-12-31 | $6.0M | −76.9% | Open → |
| FY20212021-12-31 | $26.0M | +766.7% | Open → |
| FY20202020-12-31 | $3.0M | +55.8% | Open → |
| FY20192019-12-31 | $1.9M | −48.6% | Open → |
| FY20182018-12-31 | $3.7M | −32.1% | Open → |
| FY20172017-12-31 | $5.5M | +34.5% | Open → |
| FY20162016-12-31 | $4.1M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth −7.7%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arcus Biosciences capital expenditure |url=https://companiesranked.com/en/company/arcus-biosciences/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arcus Biosciences capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/arcus-biosciences/capital-expenditureBibTeX
@misc{companiesranked-en-company-arcus-biosciences-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Arcus Biosciences capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arcus-biosciences/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001724521-26-000009 · February 25, 2026
{{cite web |title=Arcus Biosciences capital expenditure — 10-K (0001724521-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1724521/000172452126000009/rcus-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.